Evaluation of Appeal and Impact of E-Cigarettes Among Chronic Smokers With Smoking-Related Cancers

Study summary

This study will test feasibility, in smokers with lung, head \& neck, and bladder cancers, that examines the effect of e-cigarette substitution, on measures of smoking-related toxicity and medical outcomes. The aim of the study is to determine the appeal of e-cigarettes compared to regular combustible cigarettes.

Ask AI to explain this study

Start here

Key things to know

Main goalOther

This describes the study’s primary purpose.

What is being studiedHALO

The study team can explain what participation involves.

Who it may be forNicotine Dependence, Other Tobacco Product · Bladder Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Sep 19, 2019 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Dartmouth-Hitchcock Medical Center

Study sponsor

Study overview

What this study is about

Purpose: Other
Study type: Interventional
Phase: Not applicable
Sponsor: Dartmouth-Hitchcock Medical Center
Interventions being studied: Device: HALO

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

1. Histological or cytological diagnosis of lung, head \& neck, or bladder cancer within the past 5 years. 2. AJCC (American Joint Committee on Cancer) stages I-IV 3. Daily Smoking (at least 10 cigarettes per day for 10 years) and breath CO (carbon monoxide) greater than or equal to 9 ppm 4. Does not wish to quit smoking now (anyone wishing to quit smoking will be referred for smoking cessation counselling through the DHMC (Dartmouth Hitchcock Medical Center) program) 5. May be receiving anti-cancer agents 6. Age 18 or older 7. Fluent in English; 8. Patient must be capable and willing to provide informed written consent for study participation; 9. Able to participate in study visits

Reasons someone may not be able to joinExclusion criteria

1. Cancer surgery planned in the next 9 weeks; 2. Treatment with radiation planned for the next 9 weeks, 3. Actively trying to quit smoking, or planning to in the next 30 days. (If a subject reports that they plan to quit smoking in the next 30 days, we will call them after the 30 days to see if they are still trying to quit.) 4. Any use of e-cigarettes in the past 30 days, 5. Pregnant or trying to get pregnant.

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

Dartmouth Hitchcock Medical CenterLebanon, New Hampshire

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Sep 19, 2019. Always confirm current availability with the study team.

View original record ↗